New CAR T cells offer controlled treatment for solid tumors

Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells-;a type of cancer immunotherapy-;that can be switched on to varying degrees of intensity and then switched off on demand with existing drugs.

AD/PD 2024: Eli Lilly’s donanemab hit with FDA delay – Pharmaceutical Technology

Share this article The approval date for Eli Lilly’s donanemab has been pushed from the previously expected time in 1Q 2024 to a date as

March 11, 2024

Rentschler Biopharma introduces new lentiviral vector manufacturing toolbox for advanced therapies – Biotech Investments

EQS-News: Rentschler Biopharma SE / Key word(s): Product Launch Rentschler Biopharma introduces new lentiviral vector manufacturing toolbox for advanced therapies 03.09.2024 / 13:00 CET/CEST The

September 4, 2024

Early Time-Restricted Eating Cut Blood Sugar Fluctuations in Prediabetes

CHICAGO – Just 1 week of early time-restricted feeding (eTRF) cut fluctuations in blood sugar levels, and reduced the time that blood sugar was elevated,

June 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.